Crossref
Concurrent Metformin and Second-Generation Antipsychotics
The Journal of Clinical Psychiatry · 18.03.2026 · 87 (2)
DOI: 10.4088/jcp.25lr16260 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 18.03.2026. Verfasst von Louise S Mulsant und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
- Corresponding Author: Louise S. Mulsant, 1025 Queen St. West, Toronto, Ontario M6J 1H1, Canada (louise.mulsant@mail.utoronto.ca).
- Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- The Royal Hospital, Ottawa, Ontario, Canada.
Zitieren
APA
Mulsant, L. S., Husain, M. O., & Mulsant, B. H. (2026). Concurrent Metformin and Second-Generation Antipsychotics. The Journal of Clinical Psychiatry, 87(2). https://doi.org/10.4088/jcp.25lr16260
Vancouver
Mulsant LS, Husain MO, Mulsant BH. Concurrent Metformin and Second-Generation Antipsychotics. The Journal of Clinical Psychiatry. 2026;87(2). doi:10.4088/jcp.25lr16260
BibTeX
@article{Mulsant2026,
author = {Mulsant, Louise S and Husain, M Omair and Mulsant, Benoit H},
title = {Concurrent Metformin and Second-Generation Antipsychotics},
journal = {The Journal of Clinical Psychiatry},
year = {2026},
volume = {87},
number = {2},
doi = {10.4088/jcp.25lr16260}
}
EUVIMED